Articles dans des revues avec comité de lecture (463)
132.
Pécheur, E. I., Martin, I., Maier, O., Bakowsky, U., Ruysschaert, J. M., & Hoekstra, D. (2002). Phospholipid species act as modulators in p97/p47-mediated fusion of Golgi membranes. Biochemistry, 41, 9813-9823. doi:10.1021/bi0259195133.
Hoekstra, D., Martin, I., Kahya, N., Ruysschaert, J. M., & Pécheur, E. I. (2002). On the mechanism of protein-induced membrane fusion: from model to biological membranes. Cellular & Molecular Biology Letters, 7, 231-232.134.
Vigano, C., Grimard, V., Margolles, A., Goormaghtigh, E., van Veen, H., Konings, W. N., & Ruysschaert, J. M. (2002). A new experimental approach to detect long-range conformational changes transmitted between the membrane and cytosolic domains of LmrA, a bacterial multidrug transporter. FEBS letters, 530, 197-203.135.
Radresa, O., Ogata, K., Wodak, S., Ruysschaert, J. M., & Goormaghtigh, E. (2002). Modeling the three-dimensional structure of H+-ATpase of Neurospora crassa. Proposal for a proton pathway from the analysis of internal cavities. European journal of biochemistry / FEBS, 269(21), 5246-5258. doi:10.1046/j.1432-1033.2002.03236.x136.
Grimard, V., Vigano, C., Margolles, A., Wattiez, R., van Veen, H., Konings, W. N., Ruysschaert, J. M., & Goormaghtigh, E. (2001). Structure and dynamics of the membrane-embedded domain of LmrAinvestigated by coupling polarized ATR-FTIR spectroscopy and (1)H/(2)H exchange. Biochemistry, 40(39), 11876-11886.139.
Vander Stricht, D. V., Raussens, V., Oberg, K., Ruysschaert, J. M., & Goormaghtigh, E. (2001). Difference between the E1 and E2 conformations of gastric H+/K+-ATPase in a multilamellar lipid film system. Characterization by fluorescence and ATR-FTIR spectroscopy under a continuous buffer flow. European journal of biochemistry / FEBS, 268(10), 2873-2880.140.
Manciu, L., Chang, X., Riordan, J. R., Buyse, F., & Ruysschaert, J. M. (2001). Nucleotide-induced conformational changes in the human multidrug resistance protein MRP1 are related to the capacity of chemotherapeutic drugs to accumulate or not in resistant cells. FEBS letters, 493(1), 31-35.